News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,249 Results
Type
Article (41382)
Company Profile (298)
Press Release (663569)
Section
Business (207836)
Career Advice (2031)
Deals (35858)
Drug Delivery (92)
Drug Development (82416)
Employer Resources (169)
FDA (16321)
Job Trends (15058)
News (351101)
Policy (33057)
Tag
Academia (2634)
Alliances (50354)
Alzheimer's disease (1313)
Approvals (16284)
Artificial intelligence (171)
Bankruptcy (359)
Best Places to Work (11773)
Biotechnology (210)
Breast cancer (207)
Cancer (1531)
Cardiovascular disease (123)
Career advice (1696)
CAR-T (107)
Cell therapy (313)
Clinical research (65884)
Collaboration (578)
Compensation (314)
COVID-19 (2598)
C-suite (134)
Data (1483)
Diabetes (186)
Diagnostics (6287)
Earnings (86430)
Employer resources (147)
Events (113180)
Executive appointments (488)
FDA (17099)
Funding (523)
Gene therapy (222)
GLP-1 (625)
Government (4422)
Healthcare (19188)
Infectious disease (2695)
Inflammatory bowel disease (117)
Interviews (314)
IPO (16534)
Job creations (3702)
Job search strategy (1447)
Layoffs (432)
Legal (8014)
Lung cancer (224)
Manufacturing (219)
Medical device (13362)
Medtech (13367)
Mergers & acquisitions (19581)
Metabolic disorders (494)
Neuroscience (1681)
NextGen: Class of 2025 (6655)
Non-profit (4590)
Northern California (1877)
Obesity (279)
Opinion (188)
Patents (132)
People (57684)
Phase I (20540)
Phase II (28958)
Phase III (21588)
Pipeline (615)
Postmarket research (2648)
Preclinical (8968)
Radiopharmaceuticals (244)
Rare diseases (295)
Real estate (6037)
Regulatory (22166)
Research institute (2428)
Resumes & cover letters (354)
Southern California (1621)
Startups (3643)
United States (16867)
Vaccines (582)
Weight loss (195)
Date
Last 7 days (669)
Last 30 days (1898)
Last 365 days (35411)
2025 (1609)
2024 (35824)
2023 (40533)
2022 (51742)
2021 (56314)
2020 (54808)
2019 (47492)
2018 (35755)
2017 (32676)
2016 (32260)
2015 (38357)
2014 (32048)
2013 (27138)
2012 (29438)
2011 (30048)
2010 (28279)
Location
Africa (742)
Arizona (208)
Asia (38200)
Australia (6233)
California (4259)
Canada (1552)
China (358)
Colorado (192)
Connecticut (212)
Europe (83156)
Florida (605)
Georgia (146)
Illinois (420)
Indiana (243)
Maryland (684)
Massachusetts (3318)
Michigan (182)
Minnesota (317)
New Jersey (1215)
New York (1210)
North Carolina (876)
Northern California (1877)
Ohio (153)
Pennsylvania (1002)
South America (1123)
Southern California (1621)
Texas (616)
Utah (120)
Washington State (434)
705,249 Results for "model n inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Model N to be Acquired by Vista Equity Partners For $1.25 Billion
Model N announced that it has entered into a definitive agreement to be acquired by Vista Equity Partners, a leading global investment firm focused exclusively on enterprise software, data, and technology-enabled businesses.
April 8, 2024
·
10 min read
Drug Development
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
NanoViricides, Inc. reports that the ultra-broad-spectrum antiviral NV-387, a clinical Phase II stage drug candidate, was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse model.
June 20, 2024
·
10 min read
Business
Model N Announces Date of Fourth Quarter and Fiscal Year 2023 Financial Results
Model N, Inc., the leader in revenue optimization and compliance, plans to announce financial results for the fourth quarter and fiscal year 2023 after market close on Thursday, November 9, 2023.
October 19, 2023
·
1 min read
Business
Model N Responds to Mounting Regulatory Pharma Pressures with Innovations that Ensure Compliance and Optimize Revenue
Model N, the leader in revenue optimization and compliance announced new product innovations geared towards the increasingly complex regulatory environment for global pharma manufacturers.
November 7, 2023
·
4 min read
Press Releases
Cerebras Systems and Mayo Clinic Unveil Best in Class Genomic Foundation Model
January 14, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
November 22, 2024
·
7 min read
Business
Model N Announces Third Quarter Fiscal Year 2023 Financial Results
Model N, Inc., the leader in cloud revenue management solutions, announced financial results for the third quarter of fiscal year 2023 ended June 30, 2023.
August 8, 2023
·
22 min read
Biotech Bay
Model N Management to Participate in Upcoming June 2023 Investor Conferences
Model N, Inc., the leader in revenue optimization and compliance, announced that Model N management will present at the following investor conferences: The Jefferies 2023 Software Conference on Thursday, June 1, 2023 at 9:00 a.m. PT.
May 25, 2023
·
1 min read
Press Releases
Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology
January 14, 2025
·
4 min read
BioMidwest
First Patient Enrolled in Landmark Clinical Study to Assess3D Printed Models for Orthopedic Tumor Removal
Stratasys Ltd. and Ricoh USA, Inc. announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology.
June 26, 2024
·
5 min read
1 of 70,525
Next
